Table 3.
Results of the included studies
| Outcome: events (patients) | Roberts et al.20 | Roy-Chaudhury et al.19 | Sacher et al.22 | Silva et al.21 | Wong et al.23 |
|---|---|---|---|---|---|
| Patients (number) | 30 | 66 | 71 | 100 | 50 |
| Deaths | 8 | 1 | 16 | 18 | 10 |
| SCD | 2 | 0 | 4 | 7 | 8 |
| Bradycardia | — | 1461 (13) | — | — | 1031 (15) |
| Asystole | — | 14 (6) | — | — | 180 (14) |
| Bradycardia/ asystole | 3 (3) | 1475 (15) | 64 (16) | 155 (25) | — |
| VT/VF | 2 (2) | 1 | 0 | 1 | 10 (2) |
| AF | 188 (3) | 4419 (27); new onset in 22 | NR (21); new onset in 14 | 42 (13) | 4749 (21); new onset in 14 |
| AF annualized rate∗ (95% CI) | 0.07 (0.02–0.21) | 0.68 (0.45–1.03) | 0.11 (0.07–0.19) | 0.11 (0.07–0.19) | 0.19 (0.11–0.32) |
| Intervention | 3 pacemakers | 5 pacemakers | 3 pacemakers | 1 pacemaker | 1 pacemaker, 1 ICD |
AF, atrial fibrillation; CI, confidence interval; ICD, implantable cardioverter defibrillator; NR, not reported; SCD, sudden cardiac death; VF, ventricular fibrillation; VT, ventricular tachycardia.
∗
New-onset AF used when available.